 |
인쇄하기
취소
|
MSD Korea, Daewoong sign co-promotion deal for Vytorin
Published: 2011-07-04 06:58:00
Updated: 2011-07-04 06:58:00
MSD Korea and Daewoong Pharmaceuticals have recently entered into an agreement for the co-marketing of Vytorin for the treatment of high cholesterol in the domestic market following their strategic alliance of Foxamax tablets and Januvia tablets.
Vyrorin contains ezetimibe, a selective inhibitor of intestinal cholesterol and related phytosterol absorption, and simvastatin, an HMG-CoA reducta...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.